share_log

Alphabet To $136? Plus This Analyst Slashes PT On United Natural Foods

Alphabet To $136? Plus This Analyst Slashes PT On United Natural Foods

Alphabet漲到136美元？此外，這位分析師大幅抨擊聯合天然食品公司的PT
Benzinga Real-time News ·  2022/09/28 15:02
  • Truist Securities cut the price target on Alphabet Inc. (NASDAQ:GOOGL) from $145 to $136. Truist Securities analyst Youssef Squali maintained a Buy rating on the stock. Alphabet shares rose 2.5% to $99.90 on Wednesday.
  • BMO Capital cut the price target for United Natural Foods, Inc. (NYSE:UNFI) from $45 to $40. BMO Capital analyst Kelly Bania maintained the stock with a Market Perform. United Natural Foods shares fell 3.3% to $36.10 on Wednesday.
  • Wedbush raised the price target on Biogen Inc. (NASDAQ:BIIB) from $183 to $217.. Biogen shares jumped 39.7% to $276.32 on Wednesday.
  • Deutsche Bank lowered the price target for Endava plc (NYSE:DAVA) from $94 to $78. Endava shares rose 6.4% to $82.60 on Wednesday.
  • EF Hutton cut the price target on BioVie Inc. (NASDAQ:BIVI) from $14 to $8. BioVie shares rose 5.1% to $2.48 on Wednesday.
  • Deutsche Bank raised the price target for Cracker Barrel Old Country Store, Inc. (NASDAQ:CBRL) from $100 to $106. Cracker Barrel shares fell 0.2% to $97.06 on Wednesday.
  • Baird boosted the price target on Ferguson plc (NYSE:FERG) from $132 to $140. Ferguson shares rose 3.5% to $106.79 on Wednesday.
  • Truist Securities下調目標價Alphabet公司(納斯達克：谷歌)從145美元升至136美元。Truist Securities分析師優素福·斯誇利(Youssef Squali)維持對該股的買入評級。週三，Alphabet股價上漲2.5%，至99.90美元。
  • 蒙特利爾銀行資本下調目標價聯合天然食品公司(紐約證券交易所代碼：FURI)從45美元到40美元。BMO Capital分析師凱利·巴尼亞(Kelly Bania)維持了該股的市場表現。聯合自然食品股價週三下跌3.3%，至36.10美元。
  • 韋德布什將目標價上調至生物遺傳公司納斯達克：BIIB)從183美元漲至217美元。生物遺傳研究公司的股價週三上漲39.7%，至276.32美元。
  • 德意志銀行下調目標價Endava公司(紐約證券交易所代碼：DAVA)從94美元升至78美元。Endava股價週三上漲6.4%，至82.60美元。
  • EF Hutton下調目標價BioVie Inc.(納斯達克代碼：BIVI)從14美元漲至8美元。BioVie股價週三上漲5.1%，至2.48美元。
  • 德意志銀行上調目標價餅乾桶老鄉村商店，Inc.(納斯達克：CBRL)從100美元到106美元。週三，Cracker Barrel股價下跌0.2%，至97.06美元。
  • Baird上調了目標價弗格森公司(紐約證券交易所股票代碼：FERG)從132美元上漲到140美元。週三，弗格森的股價上漲3.5%，至106.79美元。

Check out this: These Analysts Boost Price Targets On Biogen Following Positive Alzheimer's Drug Data, Shares Jump

看看這個：在阿爾茨海默氏症藥物數據積極後，這些分析師上調了Biogen的目標價，股價跳漲

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論